Istanbul nightclub attack kills 39 in New Year carnage

January 1, 2017

Istanbul, Jan 1: Thirty-nine people, including many foreigners, were killed when a gunman reportedly dressed as Santa Claus stormed an Istanbul nightclub as revellers were celebrating the New Year, the latest carnage to rock Turkey after a bloody 2016.

Istanbul

The assailant shot dead a policeman and a civilian at the entrance to the Reina club, one of the city's most exclusive nightspots, and then went on a shooting rampage inside, Turkish officials said.

Interior Minister Suleyman Soylu said the attacker escaped and was now the target of a major manhunt, expressing hope the suspect "would be captured soon".

Soylu said in televised comments that of 21 victims who have been identified so far, 16 are foreigners and five are Turks. Another 69 people are being treated in hospital.

"The attacker - in the most brutal and merciless way - targeted innocent people who had only come here to celebrate the New Year and have fun," Istanbul governor Vasip Sahin said at the scene on the shores of the Bosphorus.

Many revellers threw themselves into the water in panic and efforts were under way to rescue them, NTV television said.

Dogan news agency said there were two gunmen dressed in Santa Claus outfits, although this has yet to be confirmed.

Television pictures showed party-goers - including men in suits and women in cocktail dresses - emerging from the nightclub in a state of shock.

Sahin said the attack began at 1:15 am today (local time), just after hundreds of revellers had seen in 2017 at the club in the Ortakoy district on the European side of the city.

"What happened today is a terror attack," he said.

Dogan reported that some witnesses claimed the assailants were "speaking Arabic" while NTV said special force police officers were still searching the club.

There has been no claim of responsibility.

The attack evoked memories of the November 2015 carnage in Paris when Islamic State jihadists went on a gun and bombing rampage on nightspots in the French capital, killing 130 people including 90 at the Bataclan concert hall.

From Sydney to Paris, Rio to London, security had been boosted over fears that the New Year festivities could present a target for violent extremists.

In Istanbul, at least 17,000 police officers were deployed and some, as is customary in Turkey, dressed themselves as Santa Claus as cover, according to television reports.

"Just as we were settling down, by the door there was a lot of dust and smoke. Gunshots rang out. When those sounds were heard, many girls fainted," professional footballer Sefa Boydas told AFP.

"They say 35 to 40 died but it's probably more because when I was walking, people were walking on top of people."

Dogan said there were at least 700 revellers at the elite club, where getting past the bouncers who seek out only the best dressed is notoriously hard.

Turkey has been hit by a wave of attacks blamed on Kurdish militants and IS jihadists and 2016 saw more attacks than any other year in the history of the country.

On December 10, 44 people were killed in a double bombing in Istanbul after a football match hosted by top side Besiktas, an attack claimed by the Kurdistan Freedom Falcons (TAK) seen as a radical offshoot of the outlawed PKK rebel group.

In June, 47 people were killed in a triple suicide bombing and gun attack at Istanbul's Ataturk airport, with authorities blaming IS.

And in one of the most brazen strikes, an off-duty policeman assassinated Russia's ambassador to Turkey in an Ankara art gallery less than two weeks ago.

"No terror attack will destroy our unity, or eradicate our fraternity or weaken Turkey's effective fight against terror," Justice Minister Bekir Bozdag wrote on Twitter.

Mainly Muslin Turkey's religious affairs agency Diyanet condemned the attack, saying the fact it took place in a nightclub "was no different to it being in a market or place of worship".

Turkey is still reeling from a failed July coup blamed by the government on the US-based Islamic preacher Fethullah Gulen that has been followed by a relentless purge of his alleged supporters from state institutions.

"Tragic start to 2017 in Istanbul," NATO Secretary General Jens Stoltenberg wrote on Twitter.

The White House condemned the "savagery" of the attack, with National Security Council spokesman Ned Price saying that Washington reaffirmed its support for its NATO ally "in our shared determination to confront and defeat all forms of terrorism".

The US embassy warned citizens that extremist groups are continuing "aggressive efforts to conduct attacks in areas where US citizens and expatriates reside or frequent."

Turkish President Recep Tayyip Erdogan, who is in Istanbul for the New Year, had been informed of the attack, local media said.

The shooting spree came as the Turkish army wages a four-month incursion in Syria to oust IS jihadists and Kurdish militants from the border area, suffering increasing casualties.

As is customary after such attacks in Turkey, the authorities slapped a broadcast ban on images from the incident.

Comments

Naren kotian
 - 
Sunday, 1 Jan 2017

Israel actions are totally justified ...democracies must understand how to deal with jihadist menace ...religion of piece ....while shooting ...attacker shouting religious slogans. . time has come to mercilessly attack ...bomb them ...sympathy torsidre bennige chaaku haako jana...death to Islamic state ....rip innocents party goers.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 20,2020

Paris, Jul 20: Two coronavirus vaccine candidates have proven safe for humans and produced strong immune reactions among patients involved in separate clinical trials, doctors said on Monday.

The first trial among more than 1,000 adults in Britain found that the vaccine induced "strong antibody and T cell immune responses" against the novel coronavirus.

A separate trial in China involving more than 500 people showed most had developed widespread antibody immune response.

The studies, published in The Lancet medical journal, constitute a major step on the road towards a COVID-19 vaccine that is effective and safe for widespread use.

The authors of the studies said that they encountered few adverse side-effects from the vaccine candidates.

However, they cautioned that more research was needed, particularly among older adults, who are disproportionately at risk of dying of COVID-19.

Co-author Sarah Gilbert from the University of Oxford said the results "hold promise".

"If our vaccine is effective, it is a promising option as these types of vaccine can be manufactured at large scale."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 12,2020

Kabul, Jun 12: A blast in a mosque during Friday prayers in the western part of capital Kabul has killed at least four people and wounded many more, Afghanistan's interior ministry said.

"Explosives placed inside the Sher Shah Suri Mosque exploded during Friday prayers," said a statement issued by the ministry, which added that the mosque's prayer leader Mofleh Frotan was among those killed.

Interior ministry spokesman Tariq Arian said police have cordoned off the area and helped move the wounded to ambulances and nearby hospitals.

No group immediately claimed responsibility for the attack but a mosque attack earlier this month was claimed by an ISIL (or ISIS) group affiliate, headquartered in eastern Afghanistan's Nangarhar province.

"Interestingly, every time you have the peace process gaining some momentum and pace, you have these kinds of attacks in the country," Habib Wardak, a national security analyst based in Kabul, told Al Jazeera.

"The Islamic State group claimed responsibility for the attack that happened last week on a mosque in Kabul, so despite the fact that you have these news and press conference from the government that they have eliminated ISIL, how can they conduct such sophisticated operations?"

Friday's blast had parallels to one earlier this month, when an explosion tore apart a famous Kabul mosque and led to the death of renowned Afghan cleric Maulvi Ayaz Niazi.

"In this attack, the imam seems to be the target, not the rest of the crowd. These are the imams who have supported the peace process with the Taliban movement," Wardak said.

"The other political aspect for these kinds of attacks is that there are peace spoilers trying to convey a message that peace with the Taliban will not eradicate violence in the country because you have ISIL."

Violence has spiked in recent weeks in Afghanistan with most of the attacks claimed by the ISIL affiliate.

The United States blamed the armed group for a horrific attack last month on a maternity hospital in the capital that killed 24 people, including two infants and several new mothers.

The ISIL affiliate also took responsibility for an attack on a bus carrying journalists in Kabul on May 30, killing two.

It also claimed credit for an attack on the funeral of a strongman loyal to the government last month that killed 35 people.

Meanwhile, the US is attempting to broker peace talks between the Afghan government and the Taliban to end 18 years of war.

Washington's peace envoy Zalmay Khalilzad was in the region earlier this week trying to resuscitate a US peace deal with the Taliban.

The peace deal signed in February calls for the withdrawal of the US and NATO troops from Afghanistan in return for a commitment by the Taliban to not launch attacks on the US or its allies.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.